GlassScriptPhysician profile
Zach Broyer
NPI 1093769614
$10,596.39
in general payments reported to CMS, 2019-2025
30 companies · $3,545 in 2025
The $3,545 reported for 2025 was more than what 87% of Interventional Pain Medicine providers received nationally (typical 2025 total: $676).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,790 · 2020: $189 · 2021: $1,535 · 2022: $583 · 2023: $936 · 2024: $1,018 · 2025: $3,545.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,385 · Travel and Lodging: $84.44 · Education: $30.30.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,384.81 |
| Travel and Lodging | $84.44 |
| Education | $30.30 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Liberty Surgical INC. | $2,156.35 | 2019 | |
| Globus Medical, INC. | $1,194.50 | 2025 | Senza, Omnia |
| Nevro Corp. | $1,099.23 | 2020-2024 | Senza |
| Abbott Laboratories | $1,016.12 | 2019-2025 | Eterna, Proclaim |
| Nalu Medical, INC. | $962.46 | 2021-2025 | Nalu Neurostimulation System |
| Boston Scientific Corporation | $919.60 | 2021-2025 | Intracept, General - Pain Management, Wavewriter Alpha Prime 16 |
| Medtronic, INC. | $489.05 | 2021 | |
| Arthrex, INC. | $467.50 | 2019 | |
| Biotronik Nro, INC. | $396.07 | 2025 | Prospera |
| Scilex Pharmaceuticals INC. | $325.98 | 2021-2024 | Ztlido |
| Collegium Pharmaceutical, INC. | $318.34 | 2021-2024 | Xtampza |
| Redhill Biopharma INC. | $205.68 | 2021-2022 | |
| Azurity Pharmaceuticals, INC. | $165.03 | 2023-2024 | Horizant, Horizant |
| Spinal Simplicity, LLC | $162.64 | 2025 | Ha Minuteman G3-R |
| Abbvie INC. | $125.82 | 2022-2024 | Botox |
Show all 30 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Forte Bio-Pharma LLC | $110.60 | 2022-2025 | Prolate, Tanlor, Nalocet |
| Allergan, INC. | $81.21 | 2021 | |
| Biohaven Pharmaceutical Holding Company LTD. | $53.46 | 2022 | |
| Curonix LLC | $52.72 | 2025 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Depuy Synthes Sales INC. | $51.74 | 2022-2023 | Monovisc |
| Spr Therapeutics, INC | $49.46 | 2025 | Sprint Pns System |
| Relievant Medsystems, INC. | $34.41 | 2023 | Intracept |
| Bioventus LLC | $29.21 | 2025 | Xcell |
| Saluda Medical Americas, INC. | $24.22 | 2025 | Evoke |
| Trice Medical, INC. | $21.41 | 2022 | |
| Valinor Pharma, LLC | $20.97 | 2025 | Movantik |
| Si-Bone, INC. | $17.95 | 2025 | |
| Stimwave Technologies Incorporated | $16.35 | 2021 | |
| Arbor Pharmaceuticals, INC. | $14.59 | 2021 | |
| Pfizer INC. | $13.72 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Zach Broyer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.